Antimicrobial Peptides as Promising Therapeutic Agents
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 15 September 2025 | Viewed by 88
Special Issue Editors
Interests: antimicrobial peptides; peptide—membrane interactions; natural antimicrobials; green silver nanoparticles; essential oils as antimicrobials
Special Issues, Collections and Topics in MDPI journals
Interests: antimicrobial peptides; anti-inflammatory peptides; natural antimicrobial molecules; cannabinoids as antimicrobial molecules; antimicrobial resistant bacteria
Special Issue Information
Dear Colleagues,
Antimicrobial peptides (AMPs) have garnered considerable attention as novel agents with unique mechanisms of action that can circumvent the limitations of traditional antibiotics.
AMPs are natural antibiotics and anti-virals found in several organisms, including mammals, arthropods, plants, and bacteria, and they play a key role in the innate immune system. Their broad-spectrum antimicrobial activity makes them promising candidates for therapeutic applications.
This Special Issue focuses on research studies in AMPs, including the discovery and characterization of natural or designed AMPs, chemical modifications, formulation strategies, mechanisms of action, and innovative delivery systems. In addition, we welcome the submission of studies on synergistic activity with other molecules that aim to enhance the therapeutic potential of AMPs in the fight against resistant bacteria and viruses, as well as mechanisms of resistance against AMPs.
Dr. Axel Hollmann
Dr. Paulo C Maffía
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial peptides
- peptide–membrane interactions
- antiviral peptides
- mechanism of action
- synergy
- multi-drug-resistant bacteria
- immune modulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
